109 related articles for article (PubMed ID: 27274011)
1. Methotrexate Polyglutamate Monitoring in Patients With Crohn's Disease.
Fischer M; Siva S; Cook GK; Jones DR; Fadda HM
Clin Pharmacol Drug Dev; 2017 May; 6(3):240-245. PubMed ID: 27274011
[TBL] [Abstract][Full Text] [Related]
2. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell methotrexate polyglutamate concentrations in inflammatory bowel disease.
Brooks AJ; Begg EJ; Zhang M; Frampton CM; Barclay ML
Ther Drug Monit; 2007 Oct; 29(5):619-25. PubMed ID: 17898653
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis.
Dalrymple JM; Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Barclay ML
Arthritis Rheum; 2008 Nov; 58(11):3299-308. PubMed ID: 18975321
[TBL] [Abstract][Full Text] [Related]
5. Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis.
Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
J Rheumatol; 2011 Dec; 38(12):2540-7. PubMed ID: 21965639
[TBL] [Abstract][Full Text] [Related]
6. A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.
Hobl EL; Jilma B; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Rizovski B; Mader RM
Clin Exp Rheumatol; 2012; 30(2):156-63. PubMed ID: 22152098
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study.
Woolf RT; West SL; Arenas-Hernandez M; Hare N; Peters van Ton AM; Lewis CM; Marinaki AM; Barker JN; Smith CH
Br J Dermatol; 2012 Jul; 167(1):165-73. PubMed ID: 22309614
[TBL] [Abstract][Full Text] [Related]
9. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study.
Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S
Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255
[TBL] [Abstract][Full Text] [Related]
10. The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies--a systematic review.
Mohamed HJ; Sorich MJ; Kowalski SM; McKinnon R; Proudman SM; Cleland L; Wiese MD
Eur J Clin Pharmacol; 2015 Apr; 71(4):411-23. PubMed ID: 25687918
[TBL] [Abstract][Full Text] [Related]
11. Measuring methotrexate polyglutamates.
Goodman S
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S24-6. PubMed ID: 21044429
[TBL] [Abstract][Full Text] [Related]
12. Transition of Methotrexate Polyglutamate Drug Monitoring Assay from Venipuncture to Capillary Blood-Based Collection Method in Rheumatic Diseases.
Brady K; Qu Y; Stimson D; Apilado R; Vezza Alexander R; Reddy S; Chitkara P; Conklin J; O'Malley T; Ibarra C; Dervieux T
J Appl Lab Med; 2019 Jul; 4(1):40-49. PubMed ID: 31639706
[TBL] [Abstract][Full Text] [Related]
13. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.
Dolezalová P; Krijt J; Chládek J; Nemcová D; Hoza J
Rheumatology (Oxford); 2005 Jan; 44(1):74-9. PubMed ID: 15454631
[TBL] [Abstract][Full Text] [Related]
14. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
[TBL] [Abstract][Full Text] [Related]
15. Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis.
Dervieux T; Kremer J; Lein DO; Capps R; Barham R; Meyer G; Smith K; Caldwell J; Furst DE
Pharmacogenetics; 2004 Nov; 14(11):733-9. PubMed ID: 15564880
[TBL] [Abstract][Full Text] [Related]
16. High and individually variable enzymatic activity precludes accurate determination of pemetrexed, methotrexate and their polyglutamate metabolite concentrations in plasma.
Stoop MP; Visser S; van Dijk E; Aerts JGJV; Stricker BH; Luider TM
J Pharm Biomed Anal; 2018 Jan; 148():89-92. PubMed ID: 28965049
[TBL] [Abstract][Full Text] [Related]
17. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
den Boer E; de Rotte MC; Pluijm SM; Heil SG; Hazes JM; de Jonge R
J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
[TBL] [Abstract][Full Text] [Related]
18. The methotrexate polyglutamate assay supports the efficacy of methotrexate for severe inflammatory skin disease in children.
Rahman SI; Siegfried E; Flanagan KH; Armbrecht ES
J Am Acad Dermatol; 2014 Feb; 70(2):252-6. PubMed ID: 24332314
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types.
Korell J; Duffull SB; Dalrymple JM; Drake J; Zhang M; Barclay ML; Stamp LK
Br J Clin Pharmacol; 2014 Mar; 77(3):493-7. PubMed ID: 23844933
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.
van de Meeberg MM; Fidder HH; Oldenburg B; Sundaresan J; Struys EA; Montazeri NSM; Mares WGN; Mahmmod N; van Asseldonk DP; Lutgens MWMD; Kuyvenhoven JP; Rietdijk ST; Nissen LHC; Koehestanie P; de Boer NKH; de Jonge R; Bouma G; Bulatović Ćalasan M;
Aliment Pharmacol Ther; 2023 Dec; 58(11-12):1151-1162. PubMed ID: 37767910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
